Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation.

Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation.
复制标题

芸香碱通过 MARCH8 依赖性 ABCB1 降解提高耐药细胞的抗癌药物敏感性

DOI:
10.3390/biomedicines9091143
复制
发表时间:
2021-09-02
期刊:
影响因子:
4.7
通讯作者:
Lin Z
Lin Z
中科院分区:
工程技术3区
文献类型:
--
作者:
Zou T;Zeng C;Qu J;Yan X;Lin Z

文献摘要

参考文献

被引文献

相似文献

The overexpression of adenosine triphosphate (ATP)-binding cassette (ABC) subfamily B member 1 (ABCB1; P-glycoprotein; MDR1) in some types of cancer cells is one of the mechanisms responsible for the development of multidrug resistance (MDR), which leads to the failure of chemotherapy. Therefore, it is important to inhibit the activity or reduce the expression level of ABCB1 to maintain an effective intracellular level of chemotherapeutic drugs. In this study, we found that rutaecarpine, a bioactive alkaloid isolated from Evodia Rutaecarpa, has the capacity to reverse ABCB1-mediated MDR. Our data indicated that the reversal effect of rutaecarpine was related to the attenuation of the protein level of ABCB1. Mechanistically, we demonstrated that ABCB1 is a newly discovered substrate of E3 ubiquitin ligase membrane-associated RING-CH 8 (MARCH8). MARCH8 can interact with ABCB1 and promote its ubiquitination and degradation. In short, rutaecarpine increased the degradation of ABCB1 protein by upregulating the protein level of MARCH8, thereby antagonizing ABCB1-mediated MDR. Notably, the treatment of rutaecarpine combined with other anticancer drugs exhibits a therapeutic effect on transplanted tumors. Therefore, our study provides a potential chemotherapeutic strategy of co-administrating rutaecarpine with other conventional chemotherapeutic agents to overcome MDR and improve therapeutic effect.
DOI: 10.3390/molecules15031873
发表时间: 2010-03-15
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者:
Jia S;Hu C
通讯作者: Hu C
DOI: 10.18632/oncotarget.22602
发表时间: 2017-12-08
期刊: Oncotarget
影响因子: --
作者:
Fan J;Tian L;Li M;Huang SH;Zhang J;Zhao B
通讯作者: Zhao B
DOI: 10.1182/blood.v93.5.1658
发表时间: 1999-03-01
期刊: BLOOD
影响因子: 20.3
作者:
Damiano, JS;Cress, AE;Dalton, WS
通讯作者: Dalton, WS
DOI: 10.1128/jvi.78.3.1109-1120.2004
发表时间: 2004-02-01
影响因子: 5.4
作者:
Bartee, E;Mansouri, M;Früh, K
通讯作者: Früh, K
DOI: 10.1111/j.1755-148x.2011.00841.x
发表时间: 2011-06
影响因子: 4.3
作者:
Landreville S;Agapova OA;Kneass ZT;Salesse C;Harbour JW
通讯作者: Harbour JW